{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:55:36Z","timestamp":1777413336297,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["GGH000371"],"award-info":[{"award-number":["GGH000371"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40264-015-0359-8","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T07:21:29Z","timestamp":1446880889000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports"],"prefix":"10.1007","volume":"39","author":[{"given":"Christine","family":"Njuguna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemie","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes P.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Blockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annoesjka","family":"Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briony","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehimario U.","family":"Igumbor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,7]]},"reference":[{"key":"359_CR1","unstructured":"Medicines Information Centre [Internet]. Available from: \n                    http:\/\/www.mic.uct.ac.za\/\n                    \n                  . Cited 20 Aug 2015."},{"issue":"3","key":"359_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/A:1008672311674","volume":"20","author":"H M\u00fcllerov\u00e1","year":"1998","unstructured":"M\u00fcllerov\u00e1 H, Vlcek J. European drug information centres\u2014survey of activities. Pharm World Sci. 1998;20(3):131\u20135.","journal-title":"Pharm World Sci."},{"issue":"3","key":"359_CR3","first-page":"81","volume":"5","author":"C Stubbington","year":"1998","unstructured":"Stubbington C, Bowey J, Hands D, Brown D. Drug information replies to queries involving adverse events: impact on clinical practice. Hosp Pharm. 1998;5(3):81\u20134.","journal-title":"Hosp Pharm."},{"issue":"6","key":"359_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.2042-7174.2010.00068.x","volume":"18","author":"JE McEntee","year":"2010","unstructured":"McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ. Utility and value of a medicines information service provided by pharmacists: a survey of health professionals. Int J Pharm Pract. 2010;18(6):353\u201361.","journal-title":"Int J Pharm Pract."},{"issue":"4","key":"359_CR5","first-page":"333","volume":"20","author":"B Jimmy","year":"2007","unstructured":"Jimmy B, Jose J, Rao PG. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital. Pak J Pharm Sci. 2007;20(4):333\u20139.","journal-title":"Pak J Pharm Sci."},{"issue":"161","key":"359_CR6","first-page":"216","volume":"45","author":"S Palaian","year":"2006","unstructured":"Palaian S, Mishra P, Shankar PR, Bista D, Purwar B. Contribution of the regional drug information center towards drug safety. JNMA J Nepal Med Assoc. 2006;45(161):216\u20138.","journal-title":"JNMA J Nepal Med Assoc."},{"issue":"1","key":"359_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-6405-8-4","volume":"8","author":"BS Chisholm","year":"2011","unstructured":"Chisholm BS, Cohen K, Blockman M, Kinkel H-F, Kredo TJ, Swart AM. The impact of the National HIV Health Care Worker Hotline on patient care in South Africa. AIDS Res Ther. 2011;8(1):4.","journal-title":"AIDS Res Ther."},{"issue":"3","key":"359_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1545109708318525","volume":"7","author":"LW Chang","year":"2008","unstructured":"Chang LW, Kagaayi J, Nakigozi G, Galiwango R, Mulamba J, Ludigo J, et al. Telecommunications and health care: an HIV\/AIDS warmline for communication and consultation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic). 2008;7(3):130\u20132.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)."},{"issue":"2 Suppl 2","key":"359_CR9","first-page":"8S","volume":"95","author":"RH Goldschmidt","year":"2003","unstructured":"Goldschmidt RH, Graves DW. The National HIV Telephone Consultation Service (Warmline): a clinical resource for physicians caring for African\u2013Americans. J Natl Med Assoc. 2003;95(2 Suppl 2):8S\u201311S.","journal-title":"J Natl Med Assoc."},{"issue":"6","key":"359_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1089\/tmj.2010.0220","volume":"17","author":"C Karari","year":"2011","unstructured":"Karari C, Tittle R, Penner J, Kulzer J, Bukusi EA, Marima R, et al. Evaluating the uptake, acceptability, and effectiveness of Uliza! clinicians\u2019 HIV hotline: a telephone consultation service in Kenya. Telemed J E Health. 2011;17(6):420\u20136.","journal-title":"Telemed J E Health."},{"issue":"4","key":"359_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7196\/sajhivmed.948","volume":"14","author":"AM Swart","year":"2013","unstructured":"Swart AM, Chisholm BS, Cohen K, Workman L, Cameron D, Blockman M. Analysis of queries from nurses to the South African National HIV & TB Health Care Worker Hotline. S Afr J HIV Med. 2013;14(4):179\u201382.","journal-title":"S Afr J HIV Med."},{"issue":"3","key":"359_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11096-007-9110-6","volume":"29","author":"DE Ball","year":"2007","unstructured":"Ball DE, Tagwireyi D, Maponga CC. Drug information in Zimbabwe: 1990\u20131999. Pharm World Sci. 2007;29(3):131\u20136.","journal-title":"Pharm World Sci."},{"issue":"3","key":"359_CR13","first-page":"493","volume":"11","author":"AW Tumwikirize","year":"2011","unstructured":"Tumwikirize AW, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg CS. Use of a pilot drug information centre. Afr Health Sci. 2011;11(3):493\u20138.","journal-title":"Afr Health Sci."},{"key":"359_CR14","unstructured":"World Health Organisation. The use of the WHO-UMC system for standardized case causality assessment [Internet]. The Uppsala Monitoring Centre. Available from: \n                    http:\/\/who-umc.org\/Graphics\/24734.pdf\n                    \n                  . Cited 20 Aug 2015."},{"key":"359_CR15","unstructured":"US Department of Health and Human Services. Division of AIDS table for grading the severity of adult and pediatric adverse events, Version 1.0. [Updated August 2009]. Available from: \n                    http:\/\/rsc-beta.tech-res.com\/Document\/safetyandpharmacovigilance\/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf\n                    \n                  . Cited 20 Aug 2015."},{"issue":"6","key":"359_CR16","first-page":"538","volume":"27","author":"GT Schumock","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.","journal-title":"Hosp Pharm."},{"issue":"8","key":"359_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935\u201352.","journal-title":"Am J Respir Crit Care Med."},{"issue":"6","key":"359_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1086\/650576","volume":"50","author":"SK Sharma","year":"2010","unstructured":"Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, et al. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis. 2010;50(6):833\u20139.","journal-title":"Clin Infect Dis."},{"key":"359_CR19","volume-title":"The South African Antiretroviral Treatment Guidelines","author":"Department of Health","year":"2013","unstructured":"Department of Health. The South African Antiretroviral Treatment Guidelines. Pretoria: Department of Health; 2013."},{"key":"359_CR20","volume-title":"Global tuberculosis report","author":"World Health Organisation","year":"2013","unstructured":"World Health Organisation. Global tuberculosis report. Geneva: World Health Organisation; 2013."},{"issue":"4","key":"359_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/bcp.12567","volume":"80","author":"JP Mouton","year":"2015","unstructured":"Mouton JP, Mehta U, Parrish AG, Wilson DPK, Stewart A, Njuguna CW, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharm. 2015;80(4):818\u201326.","journal-title":"Br J Clin Pharm"},{"issue":"5","key":"359_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1345\/aph.19173","volume":"34","author":"PS Melnyk","year":"2000","unstructured":"Melnyk PS, Shevchuk YM, Remillard AJ. Impact of the dial access drug information service on patient outcome. Ann Pharmacother. 2000;34(5):585\u201392.","journal-title":"Ann Pharmacother."},{"issue":"10","key":"359_CR23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/106002808702101011","volume":"21","author":"CA Repchinsky","year":"1987","unstructured":"Repchinsky CA, Masuhara EJ. Quality assurance program for a drug information center. Drug Intell Clin Pharm. 1987;21(10):816\u201320.","journal-title":"Drug Intell Clin Pharm."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-015-0359-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0359-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T22:53:06Z","timestamp":1589669586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-015-0359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,7]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s40264-015-0359-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,7]]},"assertion":[{"value":"7 November 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This research has been supported by the President\u2019s Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement Number GGH000371. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Christine Njuguna, Annemie Stewart, Johannes Mouton, Marc Blockman, Gary Maartens, Annoesjka Swart, Briony Chisholm, Jackie Jones, Mukesh Dheda, Ehimario Igumbor and Karen Cohen have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Faculty of Health Sciences Human Research Ethics Committee, University of Cape Town (UCT) and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. The UCT Human Research Ethics Committee has Federal Wide Assurance (FWA) for the Protection of Human Subjects accreditation with the US Department of Health and Human Services.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}